Cyclocondensation of (5) with different reagents gave 6-oxa-l,3,3a-5-tetraazabenzo[a]cyclopenta[h]anthracene derivatives (6,7,9a-f) and 2-(4-fluorophenyl)-14-(4-nitrophenyl)-4H-14H-7-oxa-l,4,4a,6-tetraaza-dibenzo [a,h]anthracene and 3,3-dichloro-14-(4-nitrophenyl)-3,4-dihydro-14H-7-oxa-l,4,4a,6-tetraaza dibenzo[a-h]anthracen-2-ylideneamine (10,11) respectively.
Introduction
Some recent reports' 1, 2) have adressed the biological and pharmacological activity of 2-amino- 
Results and Discussion
In the present study and in continuation of our previous work on the synthesis of polyfunctionally substituted heteroaromatics for potential utility as pharmaceuticals' 5 rearrangement did not take place as a result of using base in the medium. (9) The proposed structure of ( 8a-c) were supported by the following spectral features, the 'H NMR spectrum of (8a) as an example showed the presence of NH imino signal at δ 11.02 ppm and N=CH-at δ 8.52 ppm.
The above results encouraged us to seek a novel, simple and an one pot reaction to synthesis 2- 
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Interaction of (5) with p-fluorophenacyl bromide in presence of sodium carbonate afforded
(Scheme 2).
Scheme 2

Experimental
Melting points were uncorrected. Elemental analysis was carried out in the Microanalytical Unit National research Centre. IR spectra were recorded on Mattson 5000 FT-IR spectrometer using KBr wafer technique. 'H NMR spectra were determined on JEOL 270 MHz spectrometers using TMS as an internal standard with (δ = 0 ppm). Mass spectra were determined on FiniganSQ 700 (Japan). 
2-amino-4-(4-nitrophenyl)-4-//-benzo
N-3-cyano-4-(4-nitrophenyl)-4-H-benzo[h]chromen-2-yI]formimidic acid ethyl ester (4):
A solution of (3) 
8-imino-7-(4-nitrophenyI)-7H,8H-12-oxa-9,ll-diaza-benzo[a]anthracen-9-ylamine (5):
Hydrazine hydrate (3ml) was added to a solution of (4) in 20 ml absolute ethanol in ice bath .The reaction mixture was stirred for 4h. Then the reaction mixture was diluted with cold water .The solid formed was collected by filtration and crystallized from dioxane affording ( 5 
13-(4-nitrophenyl)-13H-6-oxa-l,3,3a-5-tetraaza-benzo[a]cyclopenta[h]anthracene ( 6) , 2-methyl-
13-(4-nitrophenyl)-13H-6-oxa-l,3!3a-5-tetraazabenzo[a]cyclopenta[h]anthracene (7):
General method : A mixture of ( 5 
